Estudios originales
Published on 15 de mayo de 2025 | http://doi.org/10.5867/medwave.2025.04.3013
Menstrual management and the impact of primary dysmenorrhea intensity on quality of life: A cross-sectional study in Chilean women
Back to article
Menstrual management and symptoms associated with dysmenorrhea (n = 392).
Menstrual management | Contraceptive methods | Combined oral contraceptive | 132 | 33.67% |
Combined injectable | 10 | 2.55% | ||
Progestin-only injectable/progestin-only oral | 18 | 4.59% | ||
Subdermal implant/levonorgestrel IUS | 19 | 4.85% | ||
Ring/patch | 7 | 1.79% | ||
Condom (internal or external) | 19 | 4.85% | ||
Surgical sterilization | 8 | 2.04% | ||
None | 179 | 45.66% | ||
Menstrual hygiene products | Menstrual panties/cloth pad | 96 | 24.49% | |
Menstrual cup/menstrual disc | 123 | 31.38% | ||
Panty liner | 108 | 27.55% | ||
Tampon | 78 | 19.90% | ||
Conventional sanitary towel | 284 | 72.45% | ||
Other | 8 | 2.04% | ||
Non-pharmacological coping strategies | Steam diffusers | 19 | 4.80% | |
Conventional hot water bottle | 159 | 40.60% | ||
Seed hot water bottle | 220 | 56.10% | ||
Herbal teas | 249 | 63.50% | ||
Massage with essential oils | 29 | 5.10% | ||
Yoga, acupuncture, Reiki, meditation | 43 | 11.00% | ||
Essential oil roll-on | 9 | 2.30% | ||
Others | 26 | 6.60% | ||
None | 52 | 13.27% | ||
Pharmacological coping strategies. | Mefenamic acid | 132 | 33.70% | |
Tranexamic acid | 9 | 2.30% | ||
Celecoxib | 35 | 8.90% | ||
Diclofenac | 4 | 1.00% | ||
Antispasmodic | 41 | 10.50% | ||
Ibuprofen | 169 | 43.10% | ||
Ketorolac | 8 | 2.00% | ||
Ketoprofen | 64 | 16.30% | ||
Naproxen | 16 | 4.10% | ||
Paracetamol | 154 | 39.30% | ||
Tramadol | 12 | 3.10% | ||
Others | 13 | 3.30% | ||
None | 39 | 9.95% | ||
Symptoms accompanying dysmenorrhea | Appetite changes | 174 | 44.40% | |
Mood changes | 312 | 79.60% | ||
Changes in bowel movements | 21 | 5.40% | ||
Headache | 222 | 56.60% | ||
Anal pain | 119 | 30.40% | ||
Lower back pain | 276 | 70.40% | ||
Fatigue | 30 | 7.70% | ||
Nausea | 146 | 37.20% | ||
Feeling of abdominal bloating | 367 | 93.60% | ||
Breast tenderness | 187 | 47.70% | ||
Vomiting | 121 | 30.90% | ||
Feeling of abdominal distension | 367 | 93.60% | ||
Breast tenderness | 187 | 47.70% | ||
Other | 20 | 5.10% |
CM, contraceptive methods. IUS, intrauterine system.
Source: Prepared by the authors based on the compiled data.